Ireland insists that the issue of pharmaceuticals should be included in tariff negotiations between the EU and the US. US President Trump has threatened to impose significant tariffs on European goods, which could adversely affect the pharmaceutical sector. The recent online meeting provided insights from the industry, emphasizing the importance of an integrated supply chain. Ireland asserts that the pharmaceutical sector is crucial for its economy and that discussions should prioritize avoiding escalatory tariffs that could harm both the EU and the US.
Ireland's position is that the treatment of pharma should be within negotiations with the EU on an agreement in principle, a crucial sector for our economy.
The integrated supply chain in pharma products between the EU and the US supports, rather than threatens, our collective transatlantic economic security.
Ultimately, when it comes to pharma, this is about achieving the best outcomes for patients and citizens on both sides of the Atlantic.
The call revealed the significant access US pharmaceutical companies have to a highly talented, skilled labour market and the EU market of over 450 million people.
Collection
[
|
...
]